
Sharon L. Turner
Examiner (ID: 4190, Phone: (571)272-0894 , Office: P/3991 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1649, 1645, 3991, 1647, 1644 |
| Total Applications | 477 |
| Issued Applications | 225 |
| Pending Applications | 85 |
| Abandoned Applications | 167 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6438993
[patent_doc_number] => 20020128211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Agent for preventing and curing hindrance of ischemic reperfusion'
[patent_app_type] => new
[patent_app_number] => 09/993194
[patent_app_country] => US
[patent_app_date] => 2001-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10368
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20020128211.pdf
[firstpage_image] =>[orig_patent_app_number] => 09993194
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/993194 | Agent for preventing and curing hindrance of ischemic reperfusion | Nov 13, 2001 | Issued |
Array
(
[id] => 748573
[patent_doc_number] => 07022314
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-04
[patent_title] => 'Anti-plaque emulsions and products containing same'
[patent_app_type] => utility
[patent_app_number] => 10/035320
[patent_app_country] => US
[patent_app_date] => 2001-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4140
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/022/07022314.pdf
[firstpage_image] =>[orig_patent_app_number] => 10035320
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/035320 | Anti-plaque emulsions and products containing same | Nov 7, 2001 | Issued |
Array
(
[id] => 6569593
[patent_doc_number] => 20020165276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Method for preventing and treating inflammatory somatic pain and chronic pain'
[patent_app_type] => new
[patent_app_number] => 10/045109
[patent_app_country] => US
[patent_app_date] => 2001-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 10155
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20020165276.pdf
[firstpage_image] =>[orig_patent_app_number] => 10045109
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/045109 | Method for preventing and treating inflammatory somatic pain and chronic pain | Nov 6, 2001 | Abandoned |
Array
(
[id] => 1096485
[patent_doc_number] => 06822001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-23
[patent_title] => 'Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents'
[patent_app_type] => B2
[patent_app_number] => 10/052905
[patent_app_country] => US
[patent_app_date] => 2001-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5608
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/822/06822001.pdf
[firstpage_image] =>[orig_patent_app_number] => 10052905
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/052905 | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents | Nov 1, 2001 | Issued |
| 10/053501 | PLAQUE REDUCING COMPOSITION | Nov 1, 2001 | Abandoned |
Array
(
[id] => 6622641
[patent_doc_number] => 20020065272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Olanzapine-N-oxide compositions and methods'
[patent_app_type] => new
[patent_app_number] => 10/016205
[patent_app_country] => US
[patent_app_date] => 2001-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3182
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20020065272.pdf
[firstpage_image] =>[orig_patent_app_number] => 10016205
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/016205 | Olanzapine-N-oxide compositions and methods | Oct 29, 2001 | Abandoned |
Array
(
[id] => 1034216
[patent_doc_number] => 06875422
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-04-05
[patent_title] => 'Oral treatment/care agent'
[patent_app_type] => utility
[patent_app_number] => 10/038565
[patent_app_country] => US
[patent_app_date] => 2001-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5475
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/875/06875422.pdf
[firstpage_image] =>[orig_patent_app_number] => 10038565
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/038565 | Oral treatment/care agent | Oct 18, 2001 | Issued |
Array
(
[id] => 6860508
[patent_doc_number] => 20030091516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Increased peroxide content tooth bleaching gel'
[patent_app_type] => new
[patent_app_number] => 10/045184
[patent_app_country] => US
[patent_app_date] => 2001-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4516
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20030091516.pdf
[firstpage_image] =>[orig_patent_app_number] => 10045184
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/045184 | Increased peroxide content tooth bleaching gel | Oct 17, 2001 | Issued |
Array
(
[id] => 6599427
[patent_doc_number] => 20020042433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-11
[patent_title] => 'R-lansoprazole compositions and methods'
[patent_app_type] => new
[patent_app_number] => 09/981108
[patent_app_country] => US
[patent_app_date] => 2001-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3390
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20020042433.pdf
[firstpage_image] =>[orig_patent_app_number] => 09981108
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/981108 | R-lansoprazole compositions and methods | Oct 16, 2001 | Abandoned |
Array
(
[id] => 7349039
[patent_doc_number] => 20040047814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Anhydrous dentrifice formulations for the delivery of incompatible ingredients'
[patent_app_type] => new
[patent_app_number] => 10/398978
[patent_app_country] => US
[patent_app_date] => 2003-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2957
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20040047814.pdf
[firstpage_image] =>[orig_patent_app_number] => 10398978
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/398978 | Anhydrous dentrifice formulations for the delivery of incompatible ingredients | Oct 9, 2001 | Issued |
Array
(
[id] => 6440022
[patent_doc_number] => 20020128280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Methods of inducing cancer cell death and tumor regression'
[patent_app_type] => new
[patent_app_number] => 09/971545
[patent_app_country] => US
[patent_app_date] => 2001-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11990
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20020128280.pdf
[firstpage_image] =>[orig_patent_app_number] => 09971545
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/971545 | Methods of inducing cancer cell death and tumor regression | Oct 4, 2001 | Issued |
| 09/968207 | Method for treating a patient with neoplasia by treatment with a gonadotropin releasing hormone analog | Oct 1, 2001 | Abandoned |
Array
(
[id] => 6477697
[patent_doc_number] => 20020022662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-21
[patent_title] => 'Enantiomers of O-desmethyl venlafaxine'
[patent_app_type] => new
[patent_app_number] => 09/957908
[patent_app_country] => US
[patent_app_date] => 2001-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5337
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20020022662.pdf
[firstpage_image] =>[orig_patent_app_number] => 09957908
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/957908 | Enantiomers of O-desmethyl venlafaxine | Sep 20, 2001 | Abandoned |
Array
(
[id] => 6622140
[patent_doc_number] => 20020065234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Method for treating neoplasia using combination chemotherapy'
[patent_app_type] => new
[patent_app_number] => 09/953585
[patent_app_country] => US
[patent_app_date] => 2001-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11018
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20020065234.pdf
[firstpage_image] =>[orig_patent_app_number] => 09953585
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/953585 | Method for treating neoplasia using combination chemotherapy | Sep 13, 2001 | Issued |
Array
(
[id] => 6080435
[patent_doc_number] => 20020081616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => '4,7-dichlorofluorescein dyes as molecular probes'
[patent_app_type] => new
[patent_app_number] => 09/949444
[patent_app_country] => US
[patent_app_date] => 2001-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6987
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20020081616.pdf
[firstpage_image] =>[orig_patent_app_number] => 09949444
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/949444 | 4,7-dichlorofluorescein dyes as molecular probes | Sep 6, 2001 | Issued |
Array
(
[id] => 6016991
[patent_doc_number] => 20020103187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Compositions and methods for treating superficial fungal infections'
[patent_app_type] => new
[patent_app_number] => 09/945638
[patent_app_country] => US
[patent_app_date] => 2001-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3485
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20020103187.pdf
[firstpage_image] =>[orig_patent_app_number] => 09945638
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/945638 | Compositions and methods for treating superficial fungal infections | Sep 3, 2001 | Issued |
Array
(
[id] => 1381482
[patent_doc_number] => 06555576
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-29
[patent_title] => 'Method for treating exercise induced asthma'
[patent_app_type] => B1
[patent_app_number] => 09/914696
[patent_app_country] => US
[patent_app_date] => 2001-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8734
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/555/06555576.pdf
[firstpage_image] =>[orig_patent_app_number] => 09914696
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/914696 | Method for treating exercise induced asthma | Aug 30, 2001 | Issued |
Array
(
[id] => 1253669
[patent_doc_number] => 06670394
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-30
[patent_title] => 'Method for treating COPD'
[patent_app_type] => B1
[patent_app_number] => 09/914703
[patent_app_country] => US
[patent_app_date] => 2001-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8618
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/670/06670394.pdf
[firstpage_image] =>[orig_patent_app_number] => 09914703
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/914703 | Method for treating COPD | Aug 30, 2001 | Issued |
Array
(
[id] => 6440239
[patent_doc_number] => 20020128296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Aspartate derivative of amlodipine'
[patent_app_type] => new
[patent_app_number] => 09/938817
[patent_app_country] => US
[patent_app_date] => 2001-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3656
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20020128296.pdf
[firstpage_image] =>[orig_patent_app_number] => 09938817
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/938817 | Aspartate derivative of amlodipine | Aug 26, 2001 | Issued |
Array
(
[id] => 6546761
[patent_doc_number] => 20020137797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Alpha-Difluoromethylornithine (DFMO) suppresses polyamine levels in the human prostate'
[patent_app_type] => new
[patent_app_number] => 09/938846
[patent_app_country] => US
[patent_app_date] => 2001-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13030
[patent_no_of_claims] => 99
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137797.pdf
[firstpage_image] =>[orig_patent_app_number] => 09938846
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/938846 | Alpha-Difluoromethylornithine (DFMO) suppresses polyamine levels in the human prostate | Aug 23, 2001 | Pending |